New pill targets hard-to-treat cancers with MAPK mutations

NCT ID NCT06326411

First seen Nov 10, 2025 · Last updated May 08, 2026 · Updated 20 times

Summary

This early-stage study tests an experimental oral drug, NST-628, in adults with advanced solid tumors that have specific genetic changes in the MAPK pathway. The main goals are to check the drug's safety, find the right dose, and see if it shrinks tumors. About 230 participants whose cancers have stopped responding to standard treatments will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cabrini Health Limited

    RECRUITING

    Malvern, Victoria, 3144, Australia

    Contact

    Contact Email: •••••@•••••

  • Cabrini Hospital

    RECRUITING

    Malvern, Victoria, 3144, Australia

    Contact

    Contact Email: •••••@•••••

  • Columbia University Medical Center

    RECRUITING

    New York, New York, 10032, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Gallipoli Medical Research Centre- Greenslopes Private Hospital

    RECRUITING

    Greenslopes, Queensland, 120, Australia

    Contact Email: •••••@•••••

    Contact

  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health

    RECRUITING

    New York, New York, 10016, United States

    Contact

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Memorial Slone Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

    Contact

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • NEXT Oncology - Austin

    ACTIVE_NOT_RECRUITING

    Austin, Texas, 78758, United States

  • NEXT Oncology - Dallas

    ACTIVE_NOT_RECRUITING

    Dallas, Texas, 75039, United States

  • NEXT Oncology - Virginia

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Roswell Park

    RECRUITING

    Buffalo, New York, 14263, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • SCRI Oncology Partners

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact Phone: •••-•••-••••

    Contact

  • START Moutain Region

    COMPLETED

    West Valley City, Utah, 84119, United States

  • Sarah Cannon Research Institute at Health ONE

    RECRUITING

    Denver, Colorado, 80218, United States

    Contact Phone: •••-•••-••••

    Contact

  • Scientia Clinical Research, Ltd

    COMPLETED

    Randwick, New South Wales, 2031, Australia

  • Southern Oncology Research Unit

    RECRUITING

    Adelaide, South Australia, 5042, Australia

    Contact

    Contact Email: •••••@•••••

  • The Kinghorn Cancer Center, St. Vincent's Health Network

    RECRUITING

    Darlinghurst, New South Wales, 2010, Australia

    Contact Email: •••••@•••••

    Contact

  • UCLA Hematology/Oncology

    RECRUITING

    Westwood, Los Angeles, California, 90024, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • UCSF Helen Diller Family Comprehensive Cancer Center

    RECRUITING

    San Francisco, California, 94158, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • UPMC Hillman Cancer Center

    RECRUITING

    Pittsburgh, Pennsylvania, 15232, United States

    Contact Email: •••••@•••••

    Contact

  • Vanderbilt-Ingram Cancer Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Yale Cancer Center

    COMPLETED

    New Haven, Connecticut, 06511, United States

Conditions

Explore the condition pages connected to this study.